Venture-Backed Startups

0 investors

0 investors

Dendro Health helps consumers improve their sleep quality through a focus on reducing overcomplexity and returning to fundamentals in sleep health. The company operates in the digital health and wellness space, addressing widespread sleep deprivation and insomnia as foundational health issues.

1 investor

1 investor

DeNet is a decentralized storage infrastructure built on its own Storage Protocol, converting unused storage capacity into secure, private storage for individuals, businesses, and AI systems. It aims to protect data and restore data ownership across sectors such as AI, healthcare, finance, and heavy industry.

1 investor

DeNexus provides an industrial cyber risk quantification and management platform that translates operational technology (OT) security vulnerabilities into financial metrics—Annual Expected Loss and Value at Risk—enabling industrial operators to prioritize remediation and communicate risk to boards and insurers. The platform serves both industrial operators seeking to manage cyber exposure and the insurance market through an agentic AI underwriting tool.

2 investors

Denglin develops GPU-based AI inference and data center products for enterprise applications including smart cities, smart computing centers, large language models, AI PCs, industrial vision, and energy management.

1 investor

Truckstop operates an online load board and freight management platform that connects carriers and shippers to facilitate the movement of goods. The company serves logistics and transportation businesses seeking streamlined freight matching and networking solutions.

6 investors

0 investors

Capacity delivers AI-powered social media support that automatically generates on-brand responses, moderates conversations, and escalates complex issues to human agents across Instagram, Facebook, LinkedIn, and X. The platform serves enterprises and brands seeking to protect reputation, drive customer engagement, and reduce response times at scale.

1 investor

Local State Farm insurance agency operated by agent Denise Irvin, offering auto, home, condo, renters, life, health, pet, and business insurance along with banking and annuity products. Based in Galloway, New Jersey, it serves individual and business customers in the surrounding area.

1 investor

Denki provides software that automates financial audit procedures—including planning, testing, and documentation—to help companies comply with regulations like SOX and SEC requirements. The platform integrates with existing audit systems and generates detailed audit workpapers with full traceability.

2 investors

DENKweit develops vision AI technology for industrial quality and data management applications. The company, a Fraunhofer spin-off based in Germany, builds image analysis systems designed to be accessible and deliver practical value across industries.

1 investor

Dennemeyer is a global intellectual property management firm offering IP law services, consulting, and proprietary software platforms for IP portfolio management and protection across multiple jurisdictions.

1 investor

Dennisson Technologies develops AURAFLEX, an advanced actuation technology that combines material science and photon physics for compact motion control applications. The company aims to provide alternatives to traditional mechanical actuation systems across various industries.

2 investors

Deno is an open-source JavaScript and TypeScript runtime with built-in tooling such as a package manager, test runner, formatter, linter, and type checker, and it is fully Node-compatible. It targets developers building server-side and web applications, offering zero-config TypeScript, granular security permissions, and web-standard APIs.

1 investor

Denodo provides a data management platform based on data virtualization, offering a universal semantic layer, data marketplace, query optimization, and governed real-time access across multiple sources for enterprises. Its capabilities target enterprise data teams building agentic AI, optimizing data lakehouse performance, and enabling self-service data sharing while maintaining centralized governance and security.

2 investors

DeNoize develops active noise-cancellation window technology that uses adaptive sound monitoring to reduce urban noise in residential spaces. The company serves homeowners and properties affected by environmental noise, operating in the acoustic comfort and sustainable building technology sector.

1 investor

Denormalized provides a serverless platform for querying and transforming real-time data streams without requiring users to manage underlying infrastructure or stream processing systems. The platform automatically infers data schemas and handles stream setup, targeting engineers who want to move data applications from development to production quickly.

1 investor

Denouncefy is a whistleblowing/complaint-channel platform that lets companies set up anonymous or identified reporting channels for issues such as workplace harassment, violence, and pay inequality. It uses AI to triage and categorize reports and encrypts data with AWS, helping Brazilian companies comply with regulations like Lei 14.457 (CIPA), NR-1, and Lei 14.611.

1 investor

DeNova develops aquafeed ingredients for feed producers in the aquaculture industry, including Psomi, a fermentation-produced protein ingredient with a complete amino acid profile. The company focuses on scalable, low-impact protein solutions to help feed producers meet nutritional and sustainability targets.

1 investor

DenovAI Biotech uses artificial intelligence and computational molecular biophysics to design proteins de novo, building platforms for rapid antibody discovery and bespoke high-affinity binders. The company targets therapeutic and diagnostic applications, including antibodies, peptide biologics, and diagnostic reporters for drug discovery.

1 investor

Denovo Sciences develops an AI platform for structure-based small-molecule drug discovery, using generative algorithms to design candidate molecules de novo within a target's binding pocket and predict their synthesizability and drug-likeness. It runs its own drug discovery programs and partners with others to identify small-molecule drug candidates, including work on broad-spectrum influenza inhibitors.

1 investor

0 investors